Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[Guillain-Barré syndrome. Its association with alpha tumor necrosis factor].

Soto-Cabrera E, Hernández-Martínez A, Yáñez H, Carrera R.

Rev Med Inst Mex Seguro Soc. 2012 Sep-Oct;50(5):565-7. Spanish.

PMID:
23282275
2.

Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.

Cesarini M, Angelucci E, Foglietta T, Vernia P.

J Crohns Colitis. 2011 Dec;5(6):619-22. doi: 10.1016/j.crohns.2011.06.010. Epub 2011 Jul 28. Review.

PMID:
22115384
3.

Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review.

Alvarez-Lario B, Prieto-Tejedo R, Colazo-Burlato M, Macarrón-Vicente J.

Clin Rheumatol. 2013 Sep;32(9):1407-12. doi: 10.1007/s10067-013-2272-9. Epub 2013 May 11. Review.

PMID:
23666317
4.

Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.

Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN.

Arthritis Rheum. 2006 May;54(5):1429-34.

5.

[Meningeal and Guillain-Barrè syndrome in a patient with rheumatoid arthritis receiving adalimumab therapy].

López Méndez P, Martín Santana I, del Pino Reyes Yánez M, Ruano Hernández A, Hernández Beriain JÁ, Hervás García M.

Reumatol Clin. 2011 Nov-Dec;7(6):401-3. doi: 10.1016/j.reuma.2011.01.009. Epub 2011 Apr 30. Spanish.

6.

Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis.

Ahmed Z, Powell R, Llewelyn G, Anstey A.

BMJ Case Rep. 2011 Dec 1;2011. pii: bcr0820114674. doi: 10.1136/bcr.08.2011.4674.

7.

Adalimumab-associated antiphospholipid syndrome: a case report and review of the literature.

Hemmati I, Kur J.

Clin Rheumatol. 2013 Jul;32(7):1095-8. doi: 10.1007/s10067-013-2244-0. Epub 2013 Apr 5. Review.

PMID:
23559388
8.

Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy.

Bouchra A, Benbouazza K, Hajjaj-Hassouni N.

Clin Rheumatol. 2009 Jun;28 Suppl 1:S53-5. doi: 10.1007/s10067-009-1154-7. Epub 2009 Mar 11.

PMID:
19277812
9.

Guillain-Barré syndrome following adalimumab treatment.

Manganelli S, Rossi M, Tuccori M, Galeazzi M.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4):592. Epub 2012 Aug 29. No abstract available.

PMID:
22931583
10.

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA.

Arthritis Res Ther. 2014 Jun 17;16(3):R125. doi: 10.1186/ar4582.

11.

Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody.

Chatani H, Tanaka M, Nagata T, Araki T, Kusunoki S.

J Clin Neurosci. 2014 Jan;21(1):170-2. doi: 10.1016/j.jocn.2013.01.015. Epub 2013 Jul 31.

PMID:
23916762
12.

Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.

Silburn S, McIvor E, McEntegart A, Wilson H.

Ann Rheum Dis. 2008 Apr;67(4):575-6. doi: 10.1136/ard.2005.043208. Review. No abstract available.

PMID:
18349168
13.

Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome.

Kokubun N, Shahrizaila N, Hirata K, Yuki N.

J Neurol Sci. 2013 Mar 15;326(1-2):111-4. doi: 10.1016/j.jns.2013.01.015. Epub 2013 Feb 8.

PMID:
23394975
14.

The Guillain-Barré syndrome.

Fujimura H.

Handb Clin Neurol. 2013;115:383-402. doi: 10.1016/B978-0-444-52902-2.00021-7. Review.

PMID:
23931791
15.

[Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].

Radziwill AJ, Kuntzer T, Steck AJ.

Rev Neurol (Paris). 2002 Mar;158(3):301-10. Review. French.

PMID:
11976589
16.

Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome.

Radhakrishnan VV, Sumi MG, Reuben S, Mathai A, Nair MD.

Indian J Med Res. 2003 May;117:216-20.

PMID:
14609050
17.

Guillain-Barré syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy.

Christodoulou C, Anastasopoulos D, Visvikis A, Mellou S, Detsi I, Tsiakalos G, Pateli A, Klouvas G, Papadimitriou A, Skarlos DV.

Anticancer Drugs. 2004 Nov;15(10):997-9.

PMID:
15514570
18.

Guillain-Barré syndrome presenting with Raynaud's phenomenon: a case report.

Gunatilake SS, Wimalaratna H.

BMC Neurol. 2014 Sep 3;14:174. doi: 10.1186/s12883-014-0174-3.

19.

A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection.

Hanzawa F, Fuchigami T, Ishii W, Nakajima S, Kawamura Y, Endo A, Arakawa C, Kohira R, Fujita Y, Takahashi S.

J Infect Chemother. 2014 Feb;20(2):134-8. doi: 10.1016/j.jiac.2013.09.010. Epub 2013 Dec 11.

PMID:
24462436
20.

Association of tumor necrosis factor polymorphisms with Guillain-Barré syndrome.

Zhang J, Dong H, Li B, Li CY, Guo L.

Eur Neurol. 2007;58(1):21-5. Epub 2007 May 4.

PMID:
17483581
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk